Ascendis Pharma A/S (ASND)
137.20
-3.90
(-2.76%)
USD |
NASDAQ |
May 03, 16:00
137.19
-0.01
(-0.01%)
After-Hours: 20:00
Ascendis Pharma Debt to Equity Ratio: -2.809 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | -2.809 |
December 31, 2023 | -3.744 |
September 30, 2023 | -7.644 |
June 30, 2023 | 7.803 |
March 31, 2023 | 3.023 |
December 31, 2022 | 1.516 |
September 30, 2022 | 1.225 |
June 30, 2022 | 0.8427 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.1188 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Date | Value |
---|---|
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-7.644
Minimum
Sep 2023
7.803
Maximum
Jun 2023
0.0166
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 866.62M |
Total Liabilities (Quarterly) | 1.124B |
Shareholders Equity (Quarterly) | -257.21M |
Current Ratio | 0.8312 |
Net Debt Paydown Yield | -0.69% |